Prostate Diseases PDF
Document Details
Uploaded by SuperiorAntigorite4686
LMU College of Dental Medicine
Tags
Summary
This document provides an overview of prostate diseases, covering topics such as prostate histology, benign prostatic hyperplasia (BPH), and prostatitis. It details the causes, symptoms, and diagnosis of these conditions, along with treatment options.
Full Transcript
Diseases of Prostate Histology of Prostate Three zones: o Transition zone: Common site of nodular hyperplasia o Central zone: Large irregular ducts o Peripheral zone: Common site of prostate CA (carcinoma) Two layers of cells: o Secretory (luminal cells): Release prostate specific antigen (PSA), pro...
Diseases of Prostate Histology of Prostate Three zones: o Transition zone: Common site of nodular hyperplasia o Central zone: Large irregular ducts o Peripheral zone: Common site of prostate CA (carcinoma) Two layers of cells: o Secretory (luminal cells): Release prostate specific antigen (PSA), prostate acid phosphate(PAP) o Basal cells: Release high molecular weight keratin, p63 Lower Urinary Tract Symptoms (LUTS) pathogenesis Static: increase in prostate size obstructs bladder Dynamic: increased smooth muscle tone Compensatory changes: Bladder hypertrophy Decompensated: residual urine, Obstructive symptoms Benign Prostate Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) LUTS: increase in prostate size BPH: Hypertrophy; increase in size of glandular portion of prostate o Not a malignant process Benign Prostate Hyperplasia (BPH) Increase Risk o High fat diet o Lots of red meat o IM testosterone replacement (NOT transdermal) o Meds § Narcotics § Antihistamines § Anticholinergic § Sympathomimetic drugs (ex. pseudoephedrine) Diagnosed via PSA release by secretory cells What is PSA? o Prostate-specific antigen (PSA) o Kallikrein related serine protease produced by secretory epithelium o Elevated serum levels seen in prostatic adenocarcinoma Digital Rectal exam (DRE): assesses size, consistency, irregularity of prostate BPH treatment o Observation o Medical § Alpha 1 adrenergic blockers § 5-alpha reductase inhibitors § PDE-5 inhibitors o Surgical Prostatitis Infection/inflammation of the prostate Causes of prostatitis o Gram negative bacilli – coliform bacteria (80%) § E. Coli § Klebsiella o Sexual transmitted bacteria – less common § Neisseria gonorrhea § Chlamydia trachomatis Complications of Prostatitis o Bladder outlet obstruction o Urinary retention o Abscess (immunocompromised patients) o Infertility o Recurrent cystitis o Pyelonephritis o Renal damage o Sepsis 4 types: o Acute Bacterial: Gram negative bacteria o Chronic Bacterial: Chronic urogenital symptoms o Chronic prostatitis/chronic pelvic pain syndrome: > 90% of all prostatitis; for at least 3 months out of 6 o Asymptomatic inflammatory prostatitis Acute Bacterial Prostatitis diagnosis o Urinalysis: positive gram stain o DRE: Boggy, tender, enlarged prostate Chronic Bacterial Prostatitis o Gram negative (similar to acute prostatitis) o E. Coli – 75-80% (most common) o Presentation § Intermittent dysuria § Intermittent obstructive LUTS § Recurrent UTI § No systemic symptoms o Diagnosis of Chronic Bacterial § Fractional urinary studies (not a urinalysis) § 4 glass urine eval - V1: Initial void (urethral) - V2: Midstream void (bladder specimen) - EPS: Expressed prostatic fluid (prostate specific), same bacteria as first specimen - V3: Post prostatic massage void, same bacteria as first specimen o Treatment: Fluoroquinolone 4-6 weeks Chronic inflammatory prostatitis/pelvic pain syndrome o Most common type o Pelvic pain or discomfort o More than 3 of the previous 6 months WITHOUT documented urinary tract infections from uropathogens